Due to the pleiotropic effects of myricetin, including anti-amyloid, anti-tau protein, anti-oxidant, anti-inflammatory and anti-dementia properties, myricetin is a promising candidate for the treatment of neurodegeneration following cerebral ischemia (Figure 1). The gene discussed is YWHAQ; the disease is Cerebral ischemia.